Corcept Director Holds Million Shares Through Rebound
Imagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
180 articlesCorcept's Selling Plan Month: What Investors Should Know
When a CFO discloses a sizable stake sale during a volatile period, investors scramble for context. This article brea...
Cathie Wood Loading This GLP-1 Stock: What It Means for Investors
A high-profile investor move has eyes turning to a GLP-1 stock with big growth potential. Here’s what it means for ri...
Cathie Wood Just This Biotech Bet: Reading the Signals
ARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Why Ataibeckley Stock Soared Today After Lilly Deal
A major biotech acquisition news drove a sharp move in ATAI shares. This article breaks down why ataibeckley stock so...
What Know About This Mineralys Insider Sale Before FDA Date
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...
Mineralys Insider Banked $557,000: Investor Insight
Insider trades can offer clues about a company’s near-term path. This article digs into a Mineralys insider banked $5...
Stock Market Today, July: AtaiBeckley Surge on Lilly Deal
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
What Does Sale Rapport Signal for Investors Today?
When a chief operating officer sells stock, investors take notice. This article breaks down the implications, explain...
Adaptive Biotechnologies Insider Sold: What Investors Should Know
Insider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
What This MeiraGTx Insider Sale Signals Momentum Ahead
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Related Topics
#Investing (146)
#Stock Analysis (44)
#Earnings Analysis (28)
#Insider Trading (28)
#Stock Market (20)
#Portfolio Strategy (16)
#Stock Market News (16)
#Earnings (14)
#Portfolio Management (12)
#Eli Lilly (10)
#Investing Strategy (9)
#SEC Filings (7)
#risk-management (6)
#Hedge Funds (6)
#CRISPR (6)